Salmeterol Xinafoate

API Product
salmeterol-xinafoate
Product Status:
Commercial
Available Grades:
  • Inhalation
Regulatory Status:
US DMF
CEP
Production Sites:
  • Hovione Loures
Product Type:
  • LABA
  • LAMA
CAS Number:
94749-08-3
Modes of Application:
  • Inhalation
Common Indications:
  • Asthma
  • COPD
Last Inspection:
FDA May 2018

Hovione can customize Salmeterol Xinafoate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.

Hovione Salmeterol Xinafoate is approved in generic applications.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Fluticasone Propionate or Tiotropium Bromide.


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

highlight

Contact Us

Please contact us if you have inquiries about our offering

http://go.hovione.com/l/47122/2014-08-06/9grc

Related files

Hovione Product Portfolio
pdf (706.84 KB)
Download